FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990266092> ?p ?o ?g. }

• W2990266092 endingPage "e190016" @default.
• W2990266092 startingPage "e190016" @default.
• W2990266092 abstract "To investigate the pathologic outcomes of additional random biopsies from areas with no visible MR targets in the setting of targeted in-bore MRI-guided biopsy and to assess the negative predictive value (NPV) of areas with no visible MR targets stratified according to patients' different biopsy statuses.A retrospective analysis of patients who underwent in-bore MRI-guided biopsy with additional random biopsies in areas with no visible MR targets (Prostate Imaging-Reporting and Data System, version 2 category 1 or 2) was conducted in this study. Diagnostic scans and in-bore MRI-guided biopsy were performed with a 3-T MRI scanner. Areas with no visible MR targets were biopsied in a random fashion whenever a zone or side did not have a visible focal target. Clinically significant cancers (CSCs) were defined as a Gleason score of 7 or greater. NPVs were stratified based on patient's prior biopsy status. Descriptive analysis was performed.A total of 59 consecutive patients were included, with a median age of 65 years (interquartile range [IQR], 59-71 years). The median prostate-specific antigen level was 7 ng/mL (IQR, 4.9-10.8 ng/mL). Of the 59 patients, 16 (27.1%) were biopsy naive, 24 (40.7%) had prior negative transrectal US-guided biopsy findings, and 19 (32.2%) had prior positive transrectal US-guided biopsy findings. Forty-two (71.2%) biopsies revealed prostate cancer. A total of 112 areas with no visible MR targets were biopsied, of which 20 (17.9%) were cancers and 11 (9.8%) were CSCs. The NPV of areas with no visible MR targets was approximately 78% for all cancers and was 88.1% for CSCs. NPVs in biopsy-naive patients, patients with prior negative transrectal US-guided biopsy findings, and patients with prior positive transrectal US-guided biopsy findings were 62.5%, 83.3%, and 84.2%, respectively, for all cancers and 75.0%, 91.7%, and 94.7%, respectively, for CSCs.Areas with no visible MR targets in patients with MR-suspicious foci may still harbor CSCs that may significantly affect management plans. Additional biopsies from areas with no visible MR targets are warranted in this population.Keywords: Biopsy/Needle Aspiration, Interventional-Body, MR-Imaging, Prostate, Urinary© RSNA, 2019." @default.
• W2990266092 created "2019-12-05" @default.
• W2990266092 creator A5004417664 @default.
• W2990266092 creator A5014010357 @default.
• W2990266092 creator A5044490149 @default.
• W2990266092 creator A5071112606 @default.
• W2990266092 creator A5082706193 @default.
• W2990266092 date "2019-11-01" @default.
• W2990266092 modified "2023-09-25" @default.
• W2990266092 title "In-Bore MRI-guided Prostate Biopsies: Retrospective Observational Study of Complementary Nontargeted Sampling of Normal-appearing Areas at Multiparametric MRI" @default.
• W2990266092 cites W1662417804 @default.
• W2990266092 cites W1827911007 @default.
• W2990266092 cites W1938383528 @default.
• W2990266092 cites W1977123955 @default.
• W2990266092 cites W2102912121 @default.
• W2990266092 cites W2179262479 @default.
• W2990266092 cites W2179709561 @default.
• W2990266092 cites W2291326553 @default.
• W2990266092 cites W2345581429 @default.
• W2990266092 cites W2517157025 @default.
• W2990266092 cites W2553196868 @default.
• W2990266092 cites W2577453388 @default.
• W2990266092 cites W2609808133 @default.
• W2990266092 cites W2766240872 @default.
• W2990266092 cites W2892370141 @default.
• W2990266092 cites W2900856478 @default.
• W2990266092 doi "https://doi.org/10.1148/rycan.2019190016" @default.
• W2990266092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7983770" @default.
• W2990266092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33778681" @default.
• W2990266092 hasPublicationYear "2019" @default.
• W2990266092 type Work @default.
• W2990266092 sameAs 2990266092 @default.
• W2990266092 citedByCount "1" @default.
• W2990266092 countsByYear W29902660922020 @default.
• W2990266092 crossrefType "journal-article" @default.
• W2990266092 hasAuthorship W2990266092A5004417664 @default.
• W2990266092 hasAuthorship W2990266092A5014010357 @default.
• W2990266092 hasAuthorship W2990266092A5044490149 @default.
• W2990266092 hasAuthorship W2990266092A5071112606 @default.
• W2990266092 hasAuthorship W2990266092A5082706193 @default.
• W2990266092 hasBestOaLocation W29902660921 @default.
• W2990266092 hasConcept C106131492 @default.
• W2990266092 hasConcept C119060515 @default.
• W2990266092 hasConcept C121608353 @default.
• W2990266092 hasConcept C126322002 @default.
• W2990266092 hasConcept C126838900 @default.
• W2990266092 hasConcept C140779682 @default.
• W2990266092 hasConcept C141071460 @default.
• W2990266092 hasConcept C142724271 @default.
• W2990266092 hasConcept C143409427 @default.
• W2990266092 hasConcept C167135981 @default.
• W2990266092 hasConcept C2775934546 @default.
• W2990266092 hasConcept C2776235491 @default.
• W2990266092 hasConcept C2780192828 @default.
• W2990266092 hasConcept C2781217009 @default.
• W2990266092 hasConcept C2989005 @default.
• W2990266092 hasConcept C31972630 @default.
• W2990266092 hasConcept C41008148 @default.
• W2990266092 hasConcept C71924100 @default.
• W2990266092 hasConceptScore W2990266092C106131492 @default.
• W2990266092 hasConceptScore W2990266092C119060515 @default.
• W2990266092 hasConceptScore W2990266092C121608353 @default.
• W2990266092 hasConceptScore W2990266092C126322002 @default.
• W2990266092 hasConceptScore W2990266092C126838900 @default.
• W2990266092 hasConceptScore W2990266092C140779682 @default.
• W2990266092 hasConceptScore W2990266092C141071460 @default.
• W2990266092 hasConceptScore W2990266092C142724271 @default.
• W2990266092 hasConceptScore W2990266092C143409427 @default.
• W2990266092 hasConceptScore W2990266092C167135981 @default.
• W2990266092 hasConceptScore W2990266092C2775934546 @default.
• W2990266092 hasConceptScore W2990266092C2776235491 @default.
• W2990266092 hasConceptScore W2990266092C2780192828 @default.
• W2990266092 hasConceptScore W2990266092C2781217009 @default.
• W2990266092 hasConceptScore W2990266092C2989005 @default.
• W2990266092 hasConceptScore W2990266092C31972630 @default.
• W2990266092 hasConceptScore W2990266092C41008148 @default.
• W2990266092 hasConceptScore W2990266092C71924100 @default.
• W2990266092 hasIssue "2" @default.
• W2990266092 hasLocation W29902660921 @default.
• W2990266092 hasLocation W29902660922 @default.
• W2990266092 hasLocation W29902660923 @default.
• W2990266092 hasOpenAccess W2990266092 @default.
• W2990266092 hasPrimaryLocation W29902660921 @default.
• W2990266092 hasRelatedWork W1551416944 @default.
• W2990266092 hasRelatedWork W1725314107 @default.
• W2990266092 hasRelatedWork W1884231116 @default.
• W2990266092 hasRelatedWork W2168798245 @default.
• W2990266092 hasRelatedWork W2394564140 @default.
• W2990266092 hasRelatedWork W2409990396 @default.
• W2990266092 hasRelatedWork W2410191098 @default.
• W2990266092 hasRelatedWork W2566665866 @default.
• W2990266092 hasRelatedWork W2785380349 @default.
• W2990266092 hasRelatedWork W3197418554 @default.
• W2990266092 hasVolume "1" @default.
• W2990266092 isParatext "false" @default.
• W2990266092 isRetracted "false" @default.
• W2990266092 magId "2990266092" @default.
• W2990266092 workType "article" @default.